Concert Pharmaceuticals, Inc.
Morphinan compounds

Abstract:

This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a .sigma.1 receptor agonist that also has NMDA antagonist activity.